17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.
about
Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP betaSoluble interleukin-6 receptor triggers osteoclast formation by interleukin 6Osteoimmunology: interactions of the bone and immune systemAlterations in osteoclast morphology following long-term 17beta-estradiol administration in the mouseEvidence that 17alpha-estradiol is biologically active in the uterine tissue: antiuterotonic and antiuterotrophic action.17Beta-estradiol suppresses TLR3-induced cytokine and chemokine production in endometrial epithelial cells.Immune regulation of osteoclast function in postmenopausal osteoporosis: a critical interdisciplinary perspectiveCiliary neurotrophic factor inhibits bone formation and plays a sex-specific role in bone growth and remodelingDisorders of bone remodelingAromatization of androgens is important for skeletal maintenance of aged male ratsInflammation as a contributing factor among postmenopausal Saudi women with osteoporosisEstrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells.p38 MAPK regulates IL-1beta induced IL-6 expression through mRNA stability in osteoblastsPhysiology of bone loss.Conjugated linoleic acid and bone biology.Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleu17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism.Interleukin-11: a new cytokine critical for osteoclast developmentFemale reproductive system and bone.Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.Low-risk stress fractures.Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow.Estrogen potentiates the combined effects of transforming growth factor-beta and tumor necrosis factor-alpha on adult human osteoblast-like cell prostaglandin E2 biosynthesisRegulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptorSuppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130.The therapeutic potential of interleukin-6 hyperagonists and antagonists.17β-estradiol ameliorates age-associated loss of fibroblast function by attenuating IFN-γ/STAT1-dependent miR-7 upregulation.Effects of conjugated linoleic acid and exercise on bone mass in young male Balb/C mice.Crosstalk between hormones and oral health in the mid-life of women: A comprehensive review.Protection by salidroside against bone loss via inhibition of oxidative stress and bone-resorbing mediators.The biochemical origin of pain--proposing a new law of pain: the origin of all pain is inflammation and the inflammatory response. Part 1 of 3--a unifying law of painEstrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB siteToremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study.Estrogen receptor signaling protects against immune suppression by UV radiation exposure.Monitoring hormone replacement therapy by biochemical markers of bone metabolism in menopausal womenTissue-engineered endometrial model for the study of cell-cell interactionsEstrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression.The role of glucocorticoids in the immediate vs. delayed effects of acute ethanol exposure on cytokine production in a binge drinking model.The anti-inflammatory role of vitamin e in prevention of osteoporosis.The Interleukin-6 inflammation pathway from cholesterol to aging--role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases
P2860
Q24329243-9F2C6B08-F32A-4300-8702-BF10C38E074DQ24563585-E83AACE6-A790-4CD8-9031-D339CAB0B26DQ24655113-8AB22514-E75E-4948-960D-0C947DD06D87Q24795446-539785A1-C06B-4338-A33F-B52BD78EE4DDQ24812462-AB31293D-1610-45B3-91BE-E675EB9B9485Q25256689-AA2FBC0B-E933-47FD-882C-4194F9B70A71Q26991927-8E58E176-3675-463F-B53F-701AFE68EAC9Q28273257-3C299322-778A-45D3-AE7A-CAB0E69DC917Q28295303-4383872E-FF52-4303-A653-BE17FC1FD4EFQ28583410-4423757C-5E47-4E3B-8553-90FE75C76A47Q28817706-BD1636CA-B3D4-4695-A300-3BEF8CF08F31Q33854310-95E6DB14-E4AE-4745-8B45-96BDF41FDE78Q33947764-08923708-EFD8-44A5-BE57-07B136027E39Q33980978-9BDBF97D-7FAF-4701-B628-E42DD479D407Q34017277-6DD7822D-58B1-4D5F-A399-5FC8ACAEDDD1Q34124460-2BBC57C2-A8A6-4AE5-B1AC-76ED7BEC4622Q34130393-8DC76F3E-005A-4606-BA47-63AECABD946AQ34138407-10AFC8F6-0E99-47F2-BFCA-638FEEBAA976Q34142868-E20E416F-C736-4AC5-BF4C-B56D878C79CEQ34143196-1ECB17E8-2D39-4F04-B811-E79406B4608EQ34155749-28CCC88A-B835-40A9-A462-60F463B74CD1Q34183981-280EA6EE-B351-47A4-A2A8-044F19E2A5A2Q34214959-0697F779-129D-47FC-AA6C-DDC8E764D6E5Q34224435-26AF2F61-D062-4131-9199-D103B94A4885Q34379185-57C9B471-CE1B-4544-9CC9-D928533985DCQ34430168-158FA663-5030-44CD-92FE-74A2DE4970E3Q34516423-C2B1BC56-A7E8-4B0C-8780-28B9AB04AC09Q34547523-F50F6CF5-C52B-4AC4-B78C-DBFD3BAA4EB1Q34586346-8A0E02C3-D5BA-491F-AFC2-3CFECA91A520Q34600281-C8752097-D188-4934-BEA8-E897C5F3DC56Q34604663-556DA916-DFE2-4C22-B7DF-68E1E718B8D4Q34630104-9EA3EC93-4FB0-4EEC-BD4A-34C631D67725Q34960850-312123E7-3799-4CA4-AC0D-3E099FF5744CQ35036477-FE39780E-F495-4499-8801-0A590866742FQ35037634-E87AFE31-70A4-4416-A814-7C9498DC13E8Q35155081-E4D7A05E-0245-4FDC-A729-434E80A60392Q35169193-B8DBCD37-5373-4F4B-A1BB-7E6CF9780558Q35545573-7DB1CC82-530D-4F1B-8661-C1BC14079261Q35580008-A7838B73-A3D1-4327-AD28-23C800DF6FE9Q35738921-95031A05-8DC3-42AB-909A-008438AE2AEF
P2860
17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
17 beta-estradiol inhibits int ...... eoporotic effect of estrogens.
@ast
17 beta-estradiol inhibits int ...... eoporotic effect of estrogens.
@en
type
label
17 beta-estradiol inhibits int ...... eoporotic effect of estrogens.
@ast
17 beta-estradiol inhibits int ...... eoporotic effect of estrogens.
@en
prefLabel
17 beta-estradiol inhibits int ...... eoporotic effect of estrogens.
@ast
17 beta-estradiol inhibits int ...... eoporotic effect of estrogens.
@en
P2093
P2860
P356
P1476
17 beta-estradiol inhibits int ...... eoporotic effect of estrogens.
@en
P2093
D C Williams
G Girasole
S C Manolagas
P2860
P304
P356
10.1172/JCI115668
P407
P577
1992-03-01T00:00:00Z